154 related articles for article (PubMed ID: 26833160)
1. Evaluation of the Efficacy of ME1111 in the Topical Treatment of Dermatophytosis in a Guinea Pig Model.
Long L; Hager C; Ghannoum M
Antimicrob Agents Chemother; 2016 Apr; 60(4):2343-5. PubMed ID: 26833160
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
Tabata Y; Takei-Masuda N; Kubota N; Takahata S; Ohyama M; Kaneda K; Iida M; Maebashi K
Antimicrob Agents Chemother; 2016 Feb; 60(2):1035-9. PubMed ID: 26643333
[TBL] [Abstract][Full Text] [Related]
3. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Pfister WR
Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
[TBL] [Abstract][Full Text] [Related]
4. In vivo antifungal activity of dipyrithione against Trichophyton rubrum on guinea pig dermatophytosis models.
Song X; Wei YX; Lai KM; He ZD; Zhang HJ
Biomed Pharmacother; 2018 Dec; 108():558-564. PubMed ID: 30243089
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antifungal efficacy in an optimized animal model of Trichophyton mentagrophytes-dermatophytosis.
Ghannoum MA; Hossain MA; Long L; Mohamed S; Reyes G; Mukherjee PK
J Chemother; 2004 Apr; 16(2):139-44. PubMed ID: 15216947
[TBL] [Abstract][Full Text] [Related]
6. VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.
Garvey EP; Hoekstra WJ; Moore WR; Schotzinger RJ; Long L; Ghannoum MA
Antimicrob Agents Chemother; 2015 Apr; 59(4):1992-7. PubMed ID: 25605358
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Kim HG; Cirino AJ; Miller AR; Mallefet P
Med Mycol; 2010 May; 48(3):491-7. PubMed ID: 20370362
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Action of ME1111, a Novel Antifungal Agent for Topical Treatment of Onychomycosis.
Takahata S; Kubota N; Takei-Masuda N; Yamada T; Maeda M; Alshahni MM; Abe S; Tabata Y; Maebashi K
Antimicrob Agents Chemother; 2016 Feb; 60(2):873-80. PubMed ID: 26596944
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activities of Astragalus verus Olivier. against Trichophyton verrucosum on in vitro and in vivo guinea pig model of dermatophytosis.
Mikaeili A; Modaresi M; Karimi I; Ghavimi H; Fathi M; Jalilian N
Mycoses; 2012 Jul; 55(4):318-25. PubMed ID: 21838718
[TBL] [Abstract][Full Text] [Related]
10.
Kubota-Ishida N; Takei-Masuda N; Kaneda K; Nagira Y; Chikada T; Nomoto M; Tabata Y; Takahata S; Maebashi K; Hui X; Maibach HI
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084749
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.
Ghannoum M; Isham N; Long L
Antimicrob Agents Chemother; 2015 Sep; 59(9):5154-8. PubMed ID: 26055386
[TBL] [Abstract][Full Text] [Related]
12. Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungals.
Saunte DM; Hasselby JP; Brillowska-Dabrowska A; Frimodt-Møller N; Svejgaard EL; Linnemann D; Nielsen SS; Haedersdal M; Arendrup MC
Med Mycol; 2008 Jun; 46(4):303-13. PubMed ID: 18415837
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of aminopyrrolnitrin against Trichophyton verrucosum in a guinea pig model of dermatophytosis.
Lee HG; Bok EY; Jung YH; Hur TY; Kim YO; Kong HJ; Kim DG; Kim YS; Oem JK
Mycoses; 2024 May; 67(5):e13748. PubMed ID: 38783563
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of NVC-422 in the treatment of dermatophytosis caused by Trichophyton mentagrophytes using a guinea pig model.
Ghannoum MA; Long L; Cirino AJ; Miller AR; Najafi R; Wang L; Sharma K; Anderson M; Memarzadeh B
Int J Dermatol; 2013 May; 52(5):567-71. PubMed ID: 23590371
[TBL] [Abstract][Full Text] [Related]
15. Antifungal ME1111 in vitro human onychopharmacokinetics.
Hui X; Jung EC; Zhu H; Maibach HI
Drug Dev Ind Pharm; 2017 Jan; 43(1):22-29. PubMed ID: 27309768
[TBL] [Abstract][Full Text] [Related]
16. A novel mycological analysis valuable for evaluating therapeutic efficacy of antimycotics against experimental dermatophytosis in guinea pigs.
Majima T; Masui S; Uchida K; Yamaguchi H
Mycoses; 2005 Mar; 48(2):108-13. PubMed ID: 15743427
[TBL] [Abstract][Full Text] [Related]
17. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
[TBL] [Abstract][Full Text] [Related]
18. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
Tatsum Y; Yokoo M; Arika T; Yamaguchi H
Microbiol Immunol; 2002; 46(7):425-32. PubMed ID: 12222928
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of the antifungal efficacy of poloxamer 407-based formulations in an infected nail plate model.
Täuber A; Müller-Goymann CC
Int J Pharm; 2016 May; 505(1-2):20-3. PubMed ID: 26992819
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis.
Nagino K; Shimohira H; Ogawa M; Uchida K; Yamaguchi H
J Infect Chemother; 2000 Mar; 6(1):41-4. PubMed ID: 11810530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
